Vera Therapeutics, Inc.
VERA
$21.71
-$0.32-1.45%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -82.13% | -69.27% | -131.95% | -67.19% | 5.61% |
| Total Depreciation and Amortization | 672.73% | 1,275.00% | 300.00% | 189.17% | 102.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 110.09% | 90.40% | 90.71% | -26.79% | -2.62% |
| Change in Net Operating Assets | -9.50% | 64.92% | 219.68% | 5,242.61% | -931.15% |
| Cash from Operations | -60.82% | -55.83% | -60.56% | -39.44% | -28.67% |
| Capital Expenditure | -- | -923.81% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 107.07% | -1,285.55% | 137.58% | 73.87% | -1,892.43% |
| Cash from Investing | 106.98% | -1,293.05% | 136.12% | 73.77% | -1,892.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.48% | 399,108.05% | 153.20% | 696.06% | 155.48% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -146.29% |
| Cash from Financing | -99.45% | 1,212.85% | 148.82% | 696.06% | 156.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -260.33% | 258.50% | 133.67% | 57.59% | -75.06% |